0
Abraxis BioScience, Inc., has announced the launch of doxorubicin HCl injection, USP 2 mg/mL, the generic equivalent of Adriamycin PFS (Bedford Labs/Boehringer Ingelheim). The productis preservative-free and latex-free.
A common diabetes drug might be able to reduce tumors faster and prolong remission in mice longer than chemotherapy alone by targeting cancer stem cells, according to Harvard researchers.
